153 related articles for article (PubMed ID: 28529574)
1. Knockdown of STMN1 enhances osteosarcoma cell chemosensitivity through inhibition of autophagy.
Wang Z; He R; Xia H; Wei Y; Wu S
Oncol Lett; 2017 May; 13(5):3465-3470. PubMed ID: 28529574
[TBL] [Abstract][Full Text] [Related]
2. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
Wang S; Akhtar J; Wang Z
Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168
[TBL] [Abstract][Full Text] [Related]
3. Stathmin1 increases radioresistance by enhancing autophagy in non-small-cell lung cancer cells.
Zhang X; Ji J; Yang Y; Zhang J; Shen L
Onco Targets Ther; 2016; 9():2565-74. PubMed ID: 27199567
[TBL] [Abstract][Full Text] [Related]
4. The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis.
Vetter NS; Kolb EA; Mills CC; Sampson VB
Mol Cancer Res; 2017 Jul; 15(7):953-964. PubMed ID: 28275089
[TBL] [Abstract][Full Text] [Related]
5. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
Zhao C; Li H; Wang L; Sun W
Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
[TBL] [Abstract][Full Text] [Related]
6. High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients.
Bai T; Yokobori T; Altan B; Ide M; Mochiki E; Yanai M; Kimura A; Kogure N; Yanoma T; Suzuki M; Bao P; Kaira K; Asao T; Katayama A; Handa T; Gombodorj N; Nishiyama M; Oyama T; Ogata K; Kuwano H
Br J Cancer; 2017 Apr; 116(9):1177-1185. PubMed ID: 28334732
[TBL] [Abstract][Full Text] [Related]
7. Cytoprotective role of autophagy during paclitaxel-induced apoptosis in Saos-2 osteosarcoma cells.
Kim HJ; Lee SG; Kim YJ; Park JE; Lee KY; Yoo YH; Kim JM
Int J Oncol; 2013 Jun; 42(6):1985-92. PubMed ID: 23563171
[TBL] [Abstract][Full Text] [Related]
8. miR-423-5p Inhibits Osteosarcoma Proliferation and Invasion Through Directly Targeting STMN1.
Wang X; Peng L; Gong X; Zhang X; Sun R; Du J
Cell Physiol Biochem; 2018; 50(6):2249-2259. PubMed ID: 30423576
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of FBXO39 inhibits proliferation and promotes apoptosis of human osteosarcoma U-2OS cells.
Zheng J; You W; Zheng C; Wan P; Chen J; Jiang X; Zhu Z; Zhang Z; Gong A; Li W; Tan J; Ji T; Guo W; Zhang S
Oncol Lett; 2018 Aug; 16(2):1849-1854. PubMed ID: 30008875
[TBL] [Abstract][Full Text] [Related]
10. Polydatin enhances the chemosensitivity of osteosarcoma cells to paclitaxel.
Zhao W; Chen Z; Guan M
J Cell Biochem; 2019 Oct; 120(10):17481-17490. PubMed ID: 31106479
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA TPT1-AS1 downregulates the microRNA-770-5p expression to inhibit glioma cell autophagy and promote proliferation through STMN1 upregulation.
Jia L; Song Y; Mu L; Li Q; Tang J; Yang Z; Meng W
J Cell Physiol; 2020 Apr; 235(4):3679-3689. PubMed ID: 31637705
[TBL] [Abstract][Full Text] [Related]
12. Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma.
Watanabe A; Suzuki H; Yokobori T; Tsukagoshi M; Altan B; Kubo N; Suzuki S; Araki K; Wada S; Kashiwabara K; Hosouchi Y; Kuwano H
Cancer Sci; 2014 Jun; 105(6):690-6. PubMed ID: 24708177
[TBL] [Abstract][Full Text] [Related]
13. Paxilitaxel induces apoptosis accompanied by protective autophagy in osteosarcoma cells through hypoxia-inducible factor-1α pathway.
Guo Y; Huang C; Li G; Chen T; Li J; Huang Z
Mol Med Rep; 2015 Sep; 12(3):3681-3687. PubMed ID: 26017247
[TBL] [Abstract][Full Text] [Related]
14. Blocked autophagy by miR-101 enhances osteosarcoma cell chemosensitivity in vitro.
Chang Z; Huo L; Li K; Wu Y; Hu Z
ScientificWorldJournal; 2014; 2014():794756. PubMed ID: 25013866
[TBL] [Abstract][Full Text] [Related]
15. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
[TBL] [Abstract][Full Text] [Related]
16. Effects of stathmin 1 silencing by siRNA on sensitivity of esophageal cancer cells Eca-109 to paclitaxel.
Zhu HW; Jiang D; Xie ZY; Zhou MH; Sun DY; Zhao YG
Genet Mol Res; 2015 Dec; 14(4):18695-702. PubMed ID: 26782519
[TBL] [Abstract][Full Text] [Related]
17. miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST.
Zhou Y; Huang Z; Wu S; Zang X; Liu M; Shi J
J Exp Clin Cancer Res; 2014 Jan; 33(1):12. PubMed ID: 24468065
[TBL] [Abstract][Full Text] [Related]
18. Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours.
Dos Santos Passaia B; Lima K; Kremer JL; da Conceição BB; de Paula Mariani BM; da Silva JCL; Zerbini MCN; Fragoso MCBV; Machado-Neto JA; Lotfi CFP
Invest New Drugs; 2020 Jun; 38(3):899-908. PubMed ID: 31441020
[TBL] [Abstract][Full Text] [Related]
19. Aberrantly high activation of a FoxM1-STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers.
Liu J; Li J; Wang K; Liu H; Sun J; Zhao X; Yu Y; Qiao Y; Wu Y; Zhang X; Zhang R; Yang A
Signal Transduct Target Ther; 2021 Feb; 6(1):42. PubMed ID: 33526768
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
